FDA | Tukaram Mundhe Cracks Down; Major Action Against Baba Ramdev-Linked Ayurvedic Drug Company, Stock Worth ₹73 Lakh Seized - English Rayat Samachar

FDA | Tukaram Mundhe Cracks Down; Major Action Against Baba Ramdev-Linked Ayurvedic Drug Company, Stock Worth ₹73 Lakh Seized

ENGLISH RAYAT SAMACHAR
2 Min Read
Sub-editor | Maryam Sayyed

Mumbai | Rayat Samachar

(FDA) Soon after assuming charge as Commissioner of the state’s Food and Drug Administration (FDA), Tukaram Mundhe reportedly initiated action against an ayurvedic medicine company associated with Baba Ramdev. According to the report, based on complaints regarding allegedly misleading advertisements and medicine-related claims, the Maharashtra FDA conducted raids at multiple locations and seized medicinal stock worth approximately ₹73.34 lakh.

(FDA) Following complaints received through various channels, action was reportedly taken at 12 ayurvedic medicine outlets and establishments across seven districts in Maharashtra. The operation was conducted under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

(FDA) The reported enforcement action focused on allegedly misleading advertisements, claims of guaranteed cures for serious illnesses, and promotional practices said to be outside regulatory norms. Products of Divya Pharmacy, based in Haridwar, were reportedly among those seized in significant quantities in multiple divisions.
The FDA reportedly conducted coordinated action across Mumbai, Pune, Nagpur, Nashik, Konkan, Amravati, and Chhatrapati Sambhajinagar divisions, seizing medicine stock valued at ₹73,34,656, with further legal proceedings said to be underway.
Tukaram Mundhe reportedly stated that no leniency would be shown toward practices that endanger public health and warned that strict action against allegedly misleading advertisements and irregular medicine sales would continue.
The reported action has allegedly caused significant discussion within Maharashtra’s ayurvedic medicine and advertising sectors.

 

Contents

 

 

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *